Atlas FDA

MEDSTONE STS-T TRANSPORTABLE LITHOTRIPTER

FDA premarket approval P870015/S030 · decided 1998-09-16

Approval details

PMA number
P870015
Supplement
S030
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
MEDSTONE STS-T TRANSPORTABLE LITHOTRIPTER
Generic name
Lithotriptor, extracorporeal shock-wave, urological
Applicant
Medstone Intl., Inc.
Date received
1998-07-17
Decision date
1998-09-16
Days to decision
61 days
Decision code
APRL
Product code
LNS
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Aliso Viejo, CA
Statement
Approval for a transportable configuration of the Medstone STS lithotripter. The devices, as modified, will be marketed under the trade name Medstone STS-T Transportable Lithotripter and is indicated for use in fragmentation of upper urinary tract stones, i.e., renal calyceal stones, renal pelvic stones, and upper ureteral stones.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MEDSTONE, UROPRO 2000, TOMOGRAPHIC OPTION (K013620)Medstone Intl., Inc.2002-01-22
STS-T LITHOTRIPTER, MODEL STS-T (K010900)Medstone Intl., Inc.2001-04-05
STS(TM) FLUOROSCOPIC IMAGING MODULE (K905278)Medstone Intl., Inc.1991-02-04